MORGAN STANLEY PLC/CALL/WALGREENS BOOTS ALLIANCE/36/0.1/20.09.24 Stock

Warrant

DE000ME1G0Q0

Market Closed - Börse Stuttgart 02:48:50 2024-06-07 pm EDT
0.003 EUR -25.00% Intraday chart for MORGAN STANLEY PLC/CALL/WALGREENS BOOTS ALLIANCE/36/0.1/20.09.24
3 months-75.00%
6 months-93.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 0.003 -25.00%
24-06-06 0.004 +33.33%
24-06-05 0.003 +50.00%
24-06-04 0.002 0.00%
24-06-03 0.002 -33.33%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 02:48 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
Issuer Morgan Stanley
WKN ME1G0Q
ISINDE000ME1G0Q0
Date issued 2023-10-03
Strike 36 $
Maturity 2024-09-20 (104 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.097
Lowest since issue 0.001
Spread 0.037
Spread %92.50%

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.84 USD
Average target price
22.21 USD
Spread / Average Target
+40.20%
Consensus